We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 17,001

Validity of Sequenom patent still to be decided
  • Foley & Lardner LLP
  • USA
  • January 27 2015

Although Sequenom has settled its dispute over U.S. Patent 6,258,540 with some parties (as I noted here), its case against Ariosa Diagnostics, Inc


Federal Circuit upholds $35 million infringement award to KFx Medical
  • Knobbe Martens Olson & Bear LLP
  • USA
  • January 22 2015

KFx Medical Corp.'s $35 million patent infringement award against Arthrex, Inc. was upheld by the Federal Circuit. KFx's lawsuit alleged that


RAND commitment relevant to damages
  • Knobbe Martens Olson & Bear LLP
  • USA
  • January 26 2015

In Ericsson, Inc. V. D-LINK SYSTEMS, Inc., Appeal Nos. 2013-1625, -1631, -1632, and -1633, the Federal Circuit affirmed-in-part and reversed-in-part


ALJ Bullock sets 16-month target date in Certain Snowmobiles (337-TA-940)
  • Oblon
  • USA
  • January 22 2015

On January 20, 2015, Chief ALJ Charles E. Bullock issued Order No. 5 in Certain Snowmobiles with Engines Having Exhaust Temperature-Controlled Engine


ALJ Pender issues claim construction order in Certain Devices Containing Non-Volatile Memory (337-TA-922)
  • Oblon
  • USA
  • January 23 2015

On January 14, 2015, ALJ Thomas B. Pender issued Order No. 10 construing the disputed claim terms of the asserted patents in Certain Devices


The Supreme Court clarifies the standard for reviewing fact-finding in claims construction
  • King & Spalding LLP
  • USA
  • January 26 2015

On January 20, 2015, the Supreme Court issued its long-awaited decision on the standard of review of factual findings by the trial court in


U.S. Supreme Court decides in Teva v. Sandoz that "evidentiary underpinnings" to claim construction are reviewed for clear error
  • Brinks Gilson & Lione
  • USA
  • January 21 2015

In Teva Pharm. USA, Inc. v. Sandoz, Inc., 574 U.S. __, No. 13-854 (2015), the Supreme Court overturned the Federal Circuit's long-standing precedent


Stanford patent found invalid in IPR proceedings but licensee’s IP survives
  • Pepper Hamilton LLP
  • USA
  • November 30 2014

In a decision this month (IPR2013-00308), the Patent Trial and Appeal Board (PTAB) has ruled against Stanford University's patented method for


The more things change, the more they stay the same - SCOTUS weighs in on standard of review for claim construction
  • Locke Lord LLP
  • USA
  • January 26 2015

On Tuesday, January 20, 2015, the Supreme Court issued its much-anticipated decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., No. 13-854


Markman ruling issues regarding semiconductor image sensor technology
  • Morris James LLP
  • USA
  • April 6 2015

Intellectual Ventures I, LLC, et al. v. Nikon Corporation, et al., C.A. No. 11-1025-SLR, March 10, 2015. The following terms are construed: